<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Hinge Health, Inc. — News on 6ix</title>
<link>https://6ix.com/company/hinge-health-inc</link>
<description>Latest news and press releases for Hinge Health, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 02 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/hinge-health-inc" rel="self" type="application/rss+xml" />
<item>
<title>Hinge Health to announce first quarter 2026 financial results on May 5, 2026</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-to-announce-first-quarter-2026-financial-results-on-may-5-2026</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-to-announce-first-quarter-2026-financial-results-on-may-5-2026</guid>
<pubDate>Thu, 02 Apr 2026 20:05:00 GMT</pubDate>
<description>SAN FRANCISCO, April 02, 2026--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026.</description>
</item>
<item>
<title>Hinge Health now supports over 300 public sector organizations including 24 state governments</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-now-supports-over-300-public-sector-organizations-including-24-state-governments-1</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-now-supports-over-300-public-sector-organizations-including-24-state-governments-1</guid>
<pubDate>Tue, 31 Mar 2026 14:00:00 GMT</pubDate>
<description>SAN FRANCISCO, March 31, 2026--Hinge Health, Inc. (NYSE: HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state employee health plan clients. With MSK conditions continuing to be a top healthcare cost driver, leading state governments are taking a different approach, prioritizing early intervention, accessibility, and evidence-based care that meets employees where they are.</description>
</item>
<item>
<title>Hinge Health appoints Tyler Sloat to its board of directors</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-appoints-tyler-sloat-to-its-board-of-directors</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-appoints-tyler-sloat-to-its-board-of-directors</guid>
<pubDate>Tue, 17 Mar 2026 20:05:00 GMT</pubDate>
<description>SAN FRANCISCO, March 17, 2026--Hinge Health, Inc. (NYSE: HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement.</description>
</item>
<item>
<title>Hinge Health reports fourth quarter and full year 2025 financial results</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-fourth-quarter-210500618</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-fourth-quarter-210500618</guid>
<pubDate>Tue, 10 Feb 2026 21:05:00 GMT</pubDate>
<description>SAN FRANCISCO, February 10, 2026--Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025.</description>
</item>
<item>
<title>Hinge Health’s 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-2026-state-musculoskeletal-160000166</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-2026-state-musculoskeletal-160000166</guid>
<pubDate>Thu, 15 Jan 2026 16:00:00 GMT</pubDate>
<description>SAN FRANCISCO, January 15, 2026--Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today’s fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider sto</description>
</item>
<item>
<title>Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-fourth-quarter-140000556</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-fourth-quarter-140000556</guid>
<pubDate>Wed, 14 Jan 2026 14:00:00 GMT</pubDate>
<description>SAN FRANCISCO, January 14, 2026--Hinge Health Q4 2025 earnings date press release</description>
</item>
<item>
<title>Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-reduces-mris-x-160000916</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-reduces-mris-x-160000916</guid>
<pubDate>Mon, 24 Nov 2025 16:00:00 GMT</pubDate>
<description>SAN FRANCISCO, November 24, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared to a similar group of individuals who sought traditional PT care. The peer-reviewed study, published in The Journal of Health Economics and Outcomes Research found that of the 4,330 participants, those who used Hinge Health had 60% fewer imaging visits for low back pain at</description>
</item>
<item>
<title>Hinge Health announces $250 million share repurchase program</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-250-million-140000483</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-250-million-140000483</guid>
<pubDate>Wed, 12 Nov 2025 14:00:00 GMT</pubDate>
<description>SAN FRANCISCO, November 12, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced that its board of directors has authorized a $250 million share repurchase program.</description>
</item>
<item>
<title>Hinge Health reports third quarter 2025 financial results</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-third-quarter-210500998</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-third-quarter-210500998</guid>
<pubDate>Tue, 04 Nov 2025 21:05:00 GMT</pubDate>
<description>SAN FRANCISCO, November 04, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2025.</description>
</item>
<item>
<title>Hinge Health unveils new AI-powered care tools</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-unveils-ai-powered-150000984</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-unveils-ai-powered-150000984</guid>
<pubDate>Tue, 21 Oct 2025 15:00:00 GMT</pubDate>
<description>SAN FRANCISCO, October 21, 2025--Hinge Health, Inc. (NYSE:HNGE) today announced two AI-powered care tools: Movement Analysis uses computer vision to set a new standard for tracking musculoskeletal (MSK) outcomes, and Robin is an AI Care Assistant that provides instant support for members. Hinge Health also published its AI care principles, which guide the development of AI across its platform.</description>
</item>
<item>
<title>Hinge Health to announce third quarter 2025 financial results on November 4, 2025</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-third-quarter-210000980</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-third-quarter-210000980</guid>
<pubDate>Wed, 01 Oct 2025 21:00:00 GMT</pubDate>
<description>SAN FRANCISCO, October 01, 2025--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025.</description>
</item>
<item>
<title>Hinge Health Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-second-quarter-200500503</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-reports-second-quarter-200500503</guid>
<pubDate>Tue, 05 Aug 2025 20:05:00 GMT</pubDate>
<description>SAN FRANCISCO, August 05, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the second quarter ended June 30, 2025.</description>
</item>
<item>
<title>Hinge Health to announce second quarter 2025 financial results on August 5, 2025</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-second-quarter-203000510</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announce-second-quarter-203000510</guid>
<pubDate>Tue, 08 Jul 2025 20:30:00 GMT</pubDate>
<description>SAN FRANCISCO, July 08, 2025--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025.</description>
</item>
<item>
<title>Hinge Health Announces HingeSelect - a High-performance Network Delivering Unified Musculoskeletal Care</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-hingeselect-high-130000176</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-hingeselect-high-130000176</guid>
<pubDate>Tue, 17 Jun 2025 13:00:00 GMT</pubDate>
<description>SAN FRANCISCO, June 17, 2025--Hinge Health, Inc. (NYSE:HNGE), today announced the launch of HingeSelect, a high-performance provider network for musculoskeletal (MSK) care. Hinge Health’s technology and in-house orthopedic physicians triage and direct downstream care, prioritizing the most appropriate evidence-based treatment. When in-person care, such as imaging or injections is required, members are seamlessly connected to pre-vetted providers at up to 50% below PPO rates. Combined with Hinge</description>
</item>
<item>
<title>Fully insured medical claims analysis shows significant cost savings and 2.4x ROI for Hinge Health populations</title>
<link>https://6ix.com/company/hinge-health-inc/news/fully-insured-medical-claims-analysis-150000612</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/fully-insured-medical-claims-analysis-150000612</guid>
<pubDate>Tue, 10 Jun 2025 15:00:00 GMT</pubDate>
<description>SAN FRANCISCO, June 10, 2025--Hinge Health, Inc. (NYSE: HNGE) today announced results from a medical claims analysis revealing an average $2,343 savings per member per year on care for chronic musculoskeletal (MSK) conditions and a 2.4x return on investment (ROI) for fully insured health plan members using its digital MSK platform. The methodology of the medical claims analysis of 4,788 health plan members was validated by Gallagher, a leading global insurance brokerage, risk management, and con</description>
</item>
<item>
<title>Hinge Health Announces Pricing of Initial Public Offering</title>
<link>https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-pricing-initial-222100703</link>
<guid isPermaLink="true">https://6ix.com/company/hinge-health-inc/news/hinge-health-announces-pricing-initial-222100703</guid>
<pubDate>Wed, 21 May 2025 22:21:00 GMT</pubDate>
<description>SAN FRANCISCO, May 21, 2025--Hinge Health today announced the pricing of its initial public offering of an aggregate 13,666,000 shares of its Class A common stock, 8,522,528 of which are being sold by Hinge Health and 5,143,472 of which are being sold by certain selling stockholders (the "Selling Stockholders"), at a public offering price of $32.00 per share. In addition, the Selling Stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,049,900 shares of Cl</description>
</item>
</channel>
</rss>